Richard Scott Struthers - 12 Feb 2024 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
President & CEO, Director
Signature
/s/ Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
12 Feb 2024
Transactions value $
$0
Form type
4
Filing time
14 Feb 2024, 16:28:29 UTC
Previous filing
13 Nov 2023
Next filing
06 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Gift $0 -60K -9.51% $0.00 571K 12 Feb 2024 By Family Trust 1 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K 12 Feb 2024 By Family Trust 2 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K 12 Feb 2024 By Family Trust 3 F1
transaction CRNX Common Stock Gift $0 +20K +22.22% $0.00 110K 12 Feb 2024 By Family Trust 4 F1
holding CRNX Common Stock 186K 12 Feb 2024 Direct
holding CRNX Common Stock 1K 12 Feb 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Bona fide gift made by the Reporting Person for no consideration.